Fox Run Management’s Vaxart VXRT Stock Holding History

Fox Run Management’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-11,588	Closed	-$58K	–	762
2022 Q1	$58K	Buy	+11,588	New	+$58.7K	0.03%	471

Other funds holding VXRT

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fox Run Management's VXRT Position: Q2 2022 in Review

Fox Run Management sold out of Vaxart (VXRT) in Q2 2022, closing a stake of 11,588 shares — an estimated $58K sold.

Fox Run Management first reported a position in VXRT in Q1 2022 and held it in 1 quarter. The position peaked at $58K in Q1 2022. 146 funds tracked by Wall St. Rank hold VXRT as of Q2 2022.

Fox Run Management reported no remaining Vaxart position as of Q2 2022 after selling out during the quarter.
Fox Run Management sold 11,588 Vaxart shares in Q2 2022, an estimated $58K.
Fox Run Management first reported a position in Vaxart in Q1 2022 and held it in 1 quarter.
Fox Run Management's Vaxart position peaked at $58K in Q1 2022.
146 funds tracked by Wall St. Rank held Vaxart as of Q2 2022.

Based on Fox Run Management's 13F filing for Q2 2022, filed 12 Aug 2022.